|
Oct. 20, 2016 |
|
|
Dec. 17, 2018 |
|
|
jRCT2080223352 |
Phase II study of BK1304 in healthy adults |
|
| version: date: |
The Research Foundation For Microbial Diseases Of Osaka University |
||
06-6877-4812 |
||
| 600 | ||
Interventional |
||
observer-blind |
||
2 |
||
Written informed consent is obtained from subject |
||
| 20age old over | ||
| 64age old under | ||
Both |
||
Prevention of influenza |
||
investigational material(s) |
||
Efficacy |
||
Immunogenicity, Safety |
||
| The Research Foundation For Microbial Diseases Of Osaka University | |
| JapicCTI-163407 | |